Contact us

Home » Streptococcus portfolio

Streptococcus portfolio

Streptococcal infections range from neonatal disease and invasive sepsis to pharyngitis and zoonotic infections. Accurate serogrouping and serotyping support diagnosis, surveillance, and vaccine research. At SSI Diagnostica Group, we provide reference materials and high‑quality antisera used by laboratories and vaccine developers worldwide. 

Product scope 

  • Group B streptococcus (GBS, also known as Streptococcus agalactiae): Type antisera Ia–IX for Neufeld (capsular reaction) and Lancefield testing and ImmuLex™ Strep‑B latex kit for rapid agglutination. 
  • Streptococcus suis: Type antisera (selected serotypes) for Neufeld (capsular reaction) and Lancefield testing. 

Methods and use 

Our portfolio supports established serological methods: 

  • Lancefield test (precipitin in capillary tube) for group confirmation and serotyping. 
  • Latex agglutination (ImmuLex™) for rapid results. 
  • Neufeld (capsular reaction / Quellung) for capsule‑expressing streptococci (e.g., S. suis and Group B Streptococcus). 

Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor.

Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl.